
Lument Finance Trust, Inc.
Buy Activity
Sell Activity
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Commercial mortgage loans held-for-investment | $76.7M-35.8% | $119.4M+11.8% | $106.8M+88.7% | $56.6M+56.5% | $36.2M |
| Cash and cash equivalents | $2.3M-13.9% | $2.7M+15.0% | $2.4M+3077.0% | $75K+159.5% | $29K |
| Securitized debt obligations | -$47.6M+38.2% | -$77.0M | — | — | — |
| Secured financing agreements | -$2.3M | $0 | — | — | — |
| Secured term loan | -$4.0M-6.2% | -$3.8M-0.3% | -$3.8M-0.1% | -$3.8M-12.6% | -$3.3M |
| Net interest income | $25.1M-39.3% | $41.4M+20.2% | $34.4M+44.1% | $23.9M+15.5% | $20.7M |
| Management and incentive fees | $4.6M-30.7% | $6.6M+52.9% | $4.3M+3.3% | $4.2M+38.0% | $3.0M |
| General and administrative expenses | $3.9M-10.2% | $4.4M+21.5% | $3.6M+4.4% | $3.5M+20.4% | $2.9M |
| Operating expenses reimbursable to Manager | $1.7M-4.2% | $1.8M-5.2% | $1.9M-10.3% | $2.1M+3.9% | $2.0M |
| Other operating expenses | $1.8M+672.1% | $234K-89.1% | $2.2M+596.7% | $310K+10.3% | $281K |
| Compensation expense | $445K+0.0% | $445K+84.5% | $241K+0.1% | $241K+20.1% | $201K |
| Total expenses | $12.5M-7.3% | $13.5M+10.2% | $12.3M+18.6% | $10.3M+22.4% | $8.4M |
| Provision for credit losses | -$14.4M-172.8% | -$5.3M-109.0% | -$2.5M+40.7% | -$4.3M | $0 |
| Net income (expense) from real estate owned operations | -$472K | $0 | — | — | — |
| Change in unrealized (loss) on mortgage servicing rights | -$95K-122.7% | -$43K+58.8% | -$104K-142.6% | $244K+168.3% | -$357K |
| Realized (loss) on sale of real estate owned | -$547K | $0 | — | — | — |
| Servicing income, net | $177K+28.9% | $137K-34.3% | $209K-39.9% | $348K-12.8% | $399K |
| Total other (loss) | -$15.3M-195.9% | -$5.2M-114.2% | -$2.4M+34.0% | -$3.7M-124.6% | -$1.6M |
| Net (loss) income before provision for income taxes | -$2.7M-112.1% | $22.7M+14.9% | $19.7M+99.7% | $9.9M-6.9% | $10.6M |
| (Provision for) income taxes | -$8K+56.4% | -$19K-228.6% | -$6K+48.4% | -$11K+85.8% | -$78K |
| Net (loss) income | -$2.7M-112.1% | $22.6M+14.9% | $19.7M+99.9% | $9.9M-6.3% | $10.5M |
| Dividends to preferred stockholders | -$4.7M+0.0% | -$4.7M+0.0% | -$4.7M+0.0% | -$4.7M-52.3% | -$3.1M |
| Net (loss) income attributable to common stockholders | -$7.5M-141.8% | $17.9M+19.6% | $15.0M+192.3% | $5.1M-30.9% | $7.4M |
| Net (loss) income attributable to common stockholders (basic) | -$7.5M-141.8% | $17.9M+19.6% | $15.0M+192.3% | $5.1M-30.9% | $7.4M |
| Net (loss) income attributable to common stockholders (diluted) | -$7.5M-141.8% | $17.9M+19.6% | $15.0M+192.3% | $5.1M-30.9% | $7.4M |
| Weighted average number of shares of common stock outstanding - basic (in shares) | 52.3M+0.1% | 52.3M | — | — | — |
| Weighted average number of shares of common stock outstanding - diluted (in shares) | 52.3M+0.1% | 52.3M+0.1% | 52.2M+8.0% | 48.3M+93.8% | 24.9M |
| Basic (loss) income per share (in dollars per share) | -$0.14-141.2% | $0.34+17.2% | $0.29+163.6% | $0.11-63.3% | $0.30 |
| Diluted (loss) income per share (in dollars per share) | -$0.14-141.2% | $0.34+17.2% | $0.29+163.6% | $0.11-63.3% | $0.30 |
| Dividends declared per weighted average share of common stock (in dollars per share) | $0.22-45.0% | $0.40+53.8% | $0.26+8.3% | $0.24-33.3% | $0.36 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 2026-05-22 | HOULIHAN WILLIAM A | Director | Purchase | 10.0K | $1.19 | $12K | 280.7K | View | |
| 2026-05-20 | 2026-05-22 | HOULIHAN WILLIAM A | Director | Purchase | 10.0K | $1.14 | $11K | 270.7K | View | |
| 2026-03-27 | 2026-04-01 | HOULIHAN WILLIAM A | Director | Purchase | 5,000 | $1.30 | $7K | 260.7K | View | |
| 2026-03-26 | 2026-03-27 | Keenan Walter C | Director | Sale | 3,600 | $19.67 | $71K | 3,900 | View | |
| 2026-03-26 | 2026-03-27 | Keenan Walter C | Director | Purchase | 6,500 | $19.60 | $127K | 10.4K | View |
Informational purposes only, not investment advice.